Evaluation of an anxiety-related phenotype in galanin overexpressing transgenic mice
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Understanding the role of neuropeptides in mediating emotional behaviors is an important avenue for discovering novel drug targets for anxiety disorders. A role for galanin in mediating anxiety-related behavior is suggested by the pattern of distribution in the CNS and the coexistence of galanin with norepinephrine in the locus coeruleus. Studies in rats have shown that central administration of galanin modulates anxiety-related behaviors, and galanin release blocks the proanxiety effects of noradrenergic activation in prestressed rats. To further investigate the role of galanin in anxiety behaviors, we conducted a comprehensive behavioral phenotyping of galanin overexpressing transgenic mice (GAL-tg). GAL-tg mice were normal on measures of general health, neurological reflexes, home cage social behaviors, sensory functions, motor coordination, and exploratory locomotor activity. In three separate tests for anxiety-related behaviors, the elevated plus-maze, light ↔ dark exploration, and open field center time, GAL-tg mice showed no anxiety-like phenotype. GAL-tg mice and wildtype littermate controls were equally responsive to the anxiolytic effects of chlordiazepoxide (10 mg/kg) in the light ↔ dark exploration test, indicating normal benzodiazepine receptor function in GAL-tg mice. Stimulation of noradrenergic cells via administration with an α2 adrenoreceptor antagonist, yohimbine (2.5 mg/kg), produced proanxiety effects in wild type mice in the light ↔ dark exploration test, but not in the GAL-tg mice. These data suggest that galanin contributes to the modulation of anxiety states induced by high levels of noradrenergic activation, but is silent under less challenging situations. A specific role for galanin in extreme anxiety states represents an attractive target for the development of novel anxiolytic treatments.
American Psyciatric Association (1994) DSM-IV, American Psychiatric Press, Washington DC.
Bale T. L., Picetti R., Contarino A., et al. (2001) Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior. J. Neurosci. 22, 193–199.
Bowser R., Kordower J. H., and Mufson E. J. (1997) A confocal microscopic analysis of galaninergic hyperinnervation of cholinergic basal forebrain neurons in Alzheimer’s disease. Brain Pathol. 7, 723–730.PubMed
Chan-Palay V. (1998) Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer’s and Parkinson’s disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia. J. Comp. Neurol. 273, 543–557.CrossRef
Cortes R., Ceccatelli S., Schalling M., and Hökfelt T. (1990) Differential effects of intracerebroventricular colchicine administration on the expression of mRNAs for neuropeptides and neurotransmitter enzymes, with special emphasis on galanin: an in situ hybridization study. Synapse 6, 369–391.PubMedCrossRef
Crabbe J. C., Wahlsten D., and Dudek B. C. (1999) Genetics of mouse behavior: interactions with laboratory environment. Science 284, 670–672.CrossRef
Crawley J. N. (2000) What Wrong with My Mouse? Behavioral Phenotyping of Transgenic and Knockout Mice, Wiley-Liss, New York.
Crawley J. N., Austin M. C., Fiske S. M., et al. (1990) Activity of centrally administered galanin fragments on stimulation of feeding behavior and on galanin receptor binding in the rat hypothalamus. J. Neurosci. 10, 695–3700.
Davis M. (1997) Neurobiology of fear responses: the role of the amygdala. J. Neuropsychiatry Clin. Neurosci. 9, 382–402.PubMed
Edwards A. V., Jarhult J., Anderson P.-O., and Bloom S. R. (1982) The importance of the pattern of stimulation in relation to the response of automatic effectors, in Systemic Role of Regulatory Peptides, Bloom, S. R. and Polak J. M. (eds.), Lindenlaub., Schattauer, Stuttgart, pp. 145–148.
Foster O. J., Chowdrey H. S., Larsen P. J., and Lightman S. L. (1992) Differential regulation of tyrosine hydroxylase, neuropeptide Y and galanin gene expression in the pons and medulla oblong at a following chronic oral administration of 2% saline: a combined in situ hybridisation and immunohistochemical study. Neuroendocrinology 55, 544–551.PubMed
Heilig M. and Widerlov E. (1995) Neurobiology and clinical aspects of neuropeptide Y. Crit. Rev. Neurobiol. 9, 115–136.PubMed
Hökfelt T., Bartfai T., and Crawley J.N. (1998a) Galanin: Basic research discoveries and therapeutic implications. Ann. N. Y. Acad. Sci. 863, xiii-xiv.CrossRef
Holmes P. V. and Crawley J. N. (1995) Coexisting neurotransmitters in central noradrenergic neurons, In Psychopharmacology: The Fourth Generation of Progress (Bloom F. E. and Kupfer D. J., eds., Raven Press, New York, pp. 347–353.
Iismaa T. P. and Shine J. (1999) Galanin and galanin receptors. Results Probl. Cell Differ. 26, 257–291.PubMed
Khoshbouei H., Cecchi M., and Morilak D. A. (1999) Interactive effects of acute stress and yohimbine on anxiety as measured with the elevated plus-maze. Soc. Neurosci. Abs. 25, 2140.
Lundberg J. M., Hedlund B., Anggard A., et al. (1982) Co-storage of peptides and classical transmitters in neurons, in Systemic Role of regulatory Peptides (Bloom S. R. and Polak J. M., eds.), Lindenlaub., Schattauer, Stuttgart, pp. 93–111.
Mathis C., Paul S. M., and Crawley J. N. (1995) Characterization of benzodiazepine-sensitive behaviors in the A/J and C57BL/6J inbred strains of mice. Behav. Genet. 24, 171–180.CrossRef
Mazarati A. M., Liu H., Soomets U., et al. (1998) Galanin modulation of seizures and seizure modulation of hippocampal galanin in animal models of status epilepticus. J. Neurosci. 18, 10,070–10,077.
Mazarati A. M., Hohmann J. G., Bacon A., et al. (2000) Modulation of hippocampal excitability and seizures by galanin. J. Neurosci. 20, 6276–6281.PubMed
Melander T., Köhler C., Nilsson S., et al. (1988) Autoradiographic quantitation and anatomical mapping of 125I-galanin binding sites in the rat central nervous system. J. Comp. Neurol. 1, 213–233.
Nishibori M., Oishi R., Itoh Y., and Saeki K. (188) Galanin inhibits noradrenaline-induced accumulation of cyclic AMP in the rat cerebral cortex. J. Neurochem. 51, 1953–1955.
Shih C. D., Chan S. H., and Chan J. Y. (1996) Participation of endogenous galanin in the suppression of baroreceptor reflex response by locus coeruleus in the rat. Brain Res. 20, 76–82.CrossRef
Shimada T., Matsumoto K., Osanai M., Matsuda H., Terasawa K., and Watanabe H. (1995) The modified light ↔ dark transition test in mice: evaluation of classic and putative anxiolytic and anxiogenic drugs. Gen. Pharmacol. 26, 205–210.PubMed
Stenzel-Poore M. P., Heinrichs S. C., Rivest S., Koob G. F., and Vale W. W. (1994) Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. J. Neurosci. 14, 2579–2584.PubMed
Tjurmina O. A., Goldstein D. S., Palkovits M., and Kopin I. J. Alpha2-adrenoceptor-mediated restraint of norepinephrine synthesis, release, and turnover during immobilization in rats. Brain Res. 826, 243–252.
Tsuda K., Yokoo H., and Goldstein M. (1989) Neuropeptide Y and galanin in norepinephrine release in hypothalamic slices. Hypertension 14, 81–86.PubMed
Tsuda K., Goldstein M., and Masuyama Y. (1990) Neuropeptide Y and galanin enhance the inhibitory effects of clonidine on norepinephrine release from medulla oblongata of rats. Am. J. Hypertens. 3, 800–802.PubMed
Tsuda K., Tsuda S., Nishio I., Masuyama Y., and Goldstein M. (1992) Modulation of norepinephrine release by galanin in rat medulla oblongata. Hypertension 20, 361–366.PubMed
van Megen H. J., Westenberg H. G., den Boer J. A., and Kahn R. S. (1995) Cholecystokinin in anxiety. Eur. Neuropsychopharmacol. 6, 263–280.
Weiss J. M., Bonsall R. W., Demetrikopoulos M. K., Emery M. S., and West C. H. Galanin: a significant role in depression? Ann. N. Y. Acad. Sci. 863, 364–382.
Xu Z. Q., Zhang X., Pieribone V. A., Grillner S., and Hökfelt T. (1998b) Galanin-5-hydroxytryptamine interactions: electrophysiological, immunohistochemical and in situ hybridization studies on rat dorsal raphe neurons with a note on galanin R1 and R2 receptors. Neuroscience 87, 79–94.PubMedCrossRef
- Evaluation of an anxiety-related phenotype in galanin overexpressing transgenic mice
Journal of Molecular Neuroscience
Volume 18, Issue 1-2 , pp 151-165
- Cover Date
- Print ISSN
- Online ISSN
- Humana Press
- Additional Links
- multitiered strategy
- transgenic mice
- elevated plus-maze
- light ↔ dark exploration test
- Industry Sectors